Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
Frontiers in Veterinary Science|May 9, 2022
Differential Effects of Natural Grazing and Feedlot Feeding on Yak Fecal MicrobiotaTariq Shah, Luming Ding, Ahmad Ud Din, et al.Transplantation|April 29, 2004
Sirolimus-associated pulmonary toxicityPhuong-Thu T Pham, Phuong-Chi T Pham, Gabriel M Danovitch, et al.Journal of Hazardous Materials|July 8, 2023
Interactive effect of silicon and zinc on cadmium toxicity alleviation in wheat plantsYing Jiang, Chang Wei, Qiujuan Jiao, et al.Peerj|June 28, 2021
Dynamics of rumen bacterial composition of yak (Bos grunniens) in response to dietary supplements during the cold seasonAnum Ali Ahmad, Jian Bo Zhang, Zeyi Liang, et al.Physiologia Plantarum|November 2, 2020
Identification of differentially expressed genes and pathways in isonuclear kenaf genotypes under salt stressFazal Munsif, Xiangjun Kong, Aziz Khan, et al.International Journal of Oncology|September 18, 2004
NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin CSaurajyoti Basu, John E Brown, G Michael Flannigan, et al.International Journal of Cancer|March 5, 2004
Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapySaurajyoti Basu, John E Brown, G Michael Flannigan, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 16, 2020
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics roleAhmad Ud Din, Maryam Mazhar, Muhammed Waseem, et al.Angewandte Chemie (International Ed. in English)|July 28, 2015
Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane AntigenSangeeta Ray Banerjee, Ethel J Ngen, Matthew W Rotz, et al.The Journal of Urology|September 6, 2006
Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancerRajiv Puri, Victor Palit, Paul M Loadman, et al.Pageof 19